Havrix®

BIOLOGICAL7 trials

Conditions

Haemophilus Influenzae Type bHepatitis AMeaslesMeasles-Mumps-Rubella VaccineMeningococcal Serogroup BMumpsNeisseria MeningitidisRubella

Phase 2

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

CompletedNCT00578175

GlaxoSmithKlineMeasles, Mumps, Rubella +1

Start: 2007-11-20End: 2009-03-17Updated: 2018-10-09

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

CompletedNCT00861744

GlaxoSmithKlineMeasles, Measles-Mumps-Rubella Vaccine, Mumps +1

Start: 2009-06-03End: 2012-06-18Updated: 2020-01-03

Phase 3

Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children

CompletedNCT00197015

GlaxoSmithKlineHepatitis A

Start: 2003-10-06End: 2009-06-09Updated: 2018-07-31

Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age

CompletedNCT01978093

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2014-02-01End: 2016-03-18Updated: 2018-09-14

Phase 4

Pilot Study of the Immunogenicity, Reactogenicity and Tolerability of Two Schedules of a 4CmenB Vaccine in Adolescents and Young Adults

CompletedNCT02583412

Canadian Immunization Research NetworkMeningococcal Serogroup B

Start: 2015-09-30End: 2017-06-30Updated: 2019-01-31

Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel

WithdrawnNCT03183492

GlaxoSmithKlineHepatitis A

Start: 2018-05-07End: 2019-01-28Updated: 2018-03-02

Unknown Phase

Study on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A Vaccine

RecruitingNCT07889219

Sinovac Biotech Co., LtdHepatitis A

Start: 2026-08-02End: 2026-11-30Target: 106Updated: 2026-10-22

2019-07-0310 citations

Immunogenicity and safety of the <i>Haemophilus influenzae</i> type b and <i>Neisseria meningitidis</i> serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in infants

Human Vaccines & Immunotherapeutics2018-09-254 citations

Two-year antibody persistence in children vaccinated at 12–15 months with a measles-mumps-rubella virus vaccine without human serum albumin

Human Vaccines & Immunotherapeutics2017-05-0811 citations

Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months

Journal of the Pediatric Infectious Diseases Society2014-08-0720 citations